Tafinlar 10 MG Tablet for Oral Suspension

RxCUI: 2632556
RxNorm name: Tafinlar 10 MG Tablet for Oral Suspension
Display name: Tafinlar 10 MG Tablet for Oral Suspension
Full name: Tafinlar 10 MG Tablet for Oral Suspension
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:30

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tafinlar	DABRAFENIB	Novartis Pharmaceuticals Corporation	fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea	2026-05-20	Warnings, Adverse reactions	Exact identifier rxcui: 2632556

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea	Tafinlar 10 MG Tablet for Oral Suspension	SY	37	These highlights do not include all the information needed to use TAFINLAR safely and effectively. See full prescribing information for TAFINLAR. TAFINLAR ® (dabrafenib) capsules, for oral use TAFINLAR ® (dabrafenib) tablets for oral suspension Initial U.S. Approval: 2013	20260520
fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea	Tafinlar 10 MG Tablet for Oral Suspension	PSN	37	These highlights do not include all the information needed to use TAFINLAR safely and effectively. See full prescribing information for TAFINLAR. TAFINLAR ® (dabrafenib) capsules, for oral use TAFINLAR ® (dabrafenib) tablets for oral suspension Initial U.S. Approval: 2013	20260520
fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea	dabrafenib 10 MG Tablet for Oral Suspension [Tafinlar]	SBD	37	These highlights do not include all the information needed to use TAFINLAR safely and effectively. See full prescribing information for TAFINLAR. TAFINLAR ® (dabrafenib) capsules, for oral use TAFINLAR ® (dabrafenib) tablets for oral suspension Initial U.S. Approval: 2013	20260520